Search Result "Myeloid Leukemia AML"
Novel and Emerging Drugs for Acute Myeloid Leukemia
Journal: Current Cancer Drug Targets
Volume: 12 Issue: 5 Year: 2012 Page: 522-530
Author(s): E. M. Stein,M. S. Tallman
Understanding Unmet Needs in the Older Acute Myeloid Leukemia (AML) Patient
Journal: Current Cancer Therapy Reviews
Volume: 12 Issue: 4 Year: 2016 Page: 246-252
Author(s): Pablo Loarte,Irina Dashkova,Leanne Tortez,Anna Dashkova,Andrzej Kozikowski,Ramy Ibrahim,Renee Pekmezaris
Immunomodulatory Drugs: IMiDs in Acute Myeloid Leukemia (AML)
Journal: Current Drug Targets
Volume: 18 Issue: 3 Year: 2017 Page: 304-314
Author(s): Joshua F. Zeidner,Matthew C. Foster
Oncogenic Signaling in Acute Myeloid Leukemia
Journal: Current Drug Targets
Volume: 8 Issue: 2 Year: 2007 Page: 237-246
Author(s): Christian H. Brandts, Wolfgang E. Berdel, Hubert Serve
Immunotherapy of Acute Myeloid Leukemia
Journal: Current Pharmaceutical Biotechnology
Volume: 2 Issue: 3 Year: 2001 Page: 209-215
Author(s): Arthur E. Frankel, Maria R. Baer, Donna E. Hogge, Robert K. Stuart
Thrombosis in Myeloid Malignancies: From CHIP to AML
Journal: Cardiovascular & Hematological Disorders-Drug Targets
Volume: 24 Issue: 1 Year: 2024 Page: 2-12
Author(s):
Epigenetics and Adult Acute Myeloid Leukemia
Journal: Current Pharmacogenomics and Personalized Medicine
Volume: 13 Issue: 2 Year: 2015 Page: 117-133
Author(s): Maël Heiblig,Mohamed El Hamri,Gilles Salles,Xavier Thomas
Inhibition of Raf Kinase in the Treatment of Acute Myeloid Leukemia
Journal: Current Pharmaceutical Design
Volume: 8 Issue: 2 Year: 2002 Page: 2243-2248
Author(s): Michael Crump
Novel Antigen Targets for Immunotherapy of Acute Myeloid Leukemia
Journal: Current Drug Targets
Volume: 18 Issue: 3 Year: 2017 Page: 296-303
Author(s): Meghali Goswami,Christopher S. Hourigan
Development of personalized molecular therapy for acute myeloid leukemia
Journal: Current Pharmaceutical Biotechnology
Volume: 17 Issue: 1 Year: 2016 Page: 20-29
Author(s): Caroline B.N. Engen,Ehsan Hajjar,Bjørn T. Gjertsen